FDA Inspection 1121634 — Shilpa Medicare Limited
The FDA completed an inspection of Shilpa Medicare Limited on Feb 25, 2020 in Jadcherla, Mahabubnagar District. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Feb 25, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jadcherla, Mahabubnagar District (India)